Would you use CTS5 to help you decide whether to offer prolonged adjuvant ET to HR+ breast cancer?
1 Answer
Mednet Member
Medical Oncology · Sarah Cannon Cancer Institute at Menorah Medical Center
Answered on
I would
Join for free or sign in to see the full answer